Literature DB >> 17077241

Causes of chronic vaginitis: analysis of a prospective database of affected women.

Paul Nyirjesy1, Christina Peyton, M Velma Weitz, Leny Mathew, Jennifer F Culhane.   

Abstract

OBJECTIVE: To compare women with different chronic vaginal symptoms with a wide variety of sociodemographic, health, behavioral, and psychosocial characteristics.
METHODS: Serially recruited subjects answered a questionnaire that asks about demographic information and symptoms and measures depression and stress scores. Patients underwent a standardized history, physical examination, and laboratory examination. Patients with recurrent vulvovaginal candidiasis, vulvar vestibulitis syndrome, desquamative inflammatory vaginitis, physiologic leukorrhea, and other diagnoses were compared with one another. Chi-square tests and one-way analysis of variance with Tukey honestly significant difference (HSD) post hoc analyses were used for categorical and continuous data analysis.
RESULTS: Two hundred patients were enrolled in this study. The most common diagnoses were contact dermatitis (21%), recurrent vulvovaginal candidiasis (20.5%), atrophic vaginitis (14.5%), and vulvar vestibulitis syndrome (12.5%); 18% of women had 2 or more diagnoses. In the overall study sample, the mean age was 38.4 years, 78% were white, and 55% were college educated. Sixty-two percent had symptoms for over a year. Desquamative inflammatory vaginitis patients were older and less likely to be menstruating. Those with vulvar vestibulitis syndrome had more frequent complaints of dyspareunia. Recurrent vulvovaginal candidiasis patients felt that their symptoms had the greatest negative impact on work and social life. There were high rates of psychiatric disorder (43.5%), atopic disease (42.5%), and pain syndrome (56%) in all groups.
CONCLUSION: Women with chronic vaginal symptoms have a variety of diagnoses, most of them noninfectious. LEVEL OF EVIDENCE: II-3.

Entities:  

Mesh:

Year:  2006        PMID: 17077241     DOI: 10.1097/01.AOG.0000239103.67452.1a

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  17 in total

1.  Postmenopausal vaginitis.

Authors:  Paul Nyirjesy
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

2.  Over-the-counter treatments and perineal hygiene in postmenopausal women.

Authors:  Elisabeth A Erekson; Deanna K Martin; E Christine Brousseau; Sallis O Yip; Terri R Fried
Journal:  Menopause       Date:  2014-03       Impact factor: 2.953

3.  High Prevalence of Sexual Dysfunction in a Vulvovaginal Specialty Clinic.

Authors:  Dina Gordon; Carolyn Gardella; David Eschenbach; Caroline M Mitchell
Journal:  J Low Genit Tract Dis       Date:  2016-01       Impact factor: 1.925

Review 4.  Candida infections of the genitourinary tract.

Authors:  Jacqueline M Achkar; Bettina C Fries
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

5.  Clinical spectrum of desquamative inflammatory vaginitis.

Authors:  Colleen Kennedy Stockdale
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

Review 6.  Allergic vulvovaginitis: a systematic literature review.

Authors:  Ana Sofia Oliveira; Joana Rolo; Carlos Gaspar; Rita Palmeira de Oliveira; José Martinez de Oliveira; Ana Palmeira de Oliveira
Journal:  Arch Gynecol Obstet       Date:  2021-11-26       Impact factor: 2.493

7.  Vaginal toxic shock reaction triggering desquamative inflammatory vaginitis.

Authors:  Nigel Pereira; Thomas D Edlind; Patrick M Schlievert; Paul Nyirjesy
Journal:  J Low Genit Tract Dis       Date:  2013-01       Impact factor: 1.925

8.  Real-world effectiveness and tolerability of Zelesse cream® for treating vulvovaginitis in adult women: an observational, prospective study.

Authors:  Ana Rosa Masero; Luís Manuel San Frutos; Ernesto Vizcaíno; María Palma; Syra Velasco-Ortega; Concepción Nieto
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

9.  Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA.

Authors:  Samuel Aballéa; Florent Guelfucci; Julian Wagner; Amine Khemiri; Jean-Paul Dietz; Jack Sobel; Mondher Toumi
Journal:  Health Qual Life Outcomes       Date:  2013-10-11       Impact factor: 3.186

10.  Lamisil versus clotrimazole in the treatment of vulvovaginal candidiasis.

Authors:  Ali Zarei Mahmoudabadi; Mahin Najafyan; Eskandar Moghimipour; Maryam Alwanian; Zahra Seifi
Journal:  Iran J Microbiol       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.